Pancreatic Cancer Research

ResearcherSoochow UniversityActive in the last 2 years

Bo Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6505-2771; OpenAlex author ID A5017652215. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 4

  1. IGF2BP2 stabilized by USP7 promotes cancer-associated fibroblast activation and attenuates gemcitabine sensitivity in PDAC. Last author DOI 10.1016/j.celrep.2025.116476↗
  2. Cancer-associated fibroblasts drive early pancreatic cancer cell invasion via the SOX4/MMP11 signalling axis. Co-author DOI 10.1016/j.bbadis.2023.166852↗
  3. Bortezomib-induced apoptosis in cultured pancreatic cancer cells is associated with ceramide production. First author DOI 10.1007/s00280-013-2318-3↗
  4. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer … Co-author DOI 10.1186/1471-2407-14-373↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qiaojun He · 2 shared papers, 2024–2025 · strength 0.42
  2. Fujing Ge · 2 shared papers, 2024–2025 · strength 0.42
  3. Liu Yang · 2 shared papers, 2024–2025 · strength 0.42
  4. Xin Dong · 1 shared paper, 2025 · strength 0.21
  5. Yulian Wu · 1 shared paper, 2025 · strength 0.21
  6. Lei Gong · 1 shared paper, 2014 · strength 0.04
  7. Gaojue Wu · 1 shared paper, 2014 · strength 0.04
  8. Cong Cao · 1 shared paper, 2014 · strength 0.04
  9. Xingdong Xu · 1 shared paper, 2014 · strength 0.04
  10. Quansheng Zhou · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.